Lupinacci R, Rupp R, Wittawatmongkol O, Jones J, et al. A phase 3, multicenter, randomized, double-blind, active-comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of a 4-dose regimen of V114, a 15-valent pneumococcal conjugate vaccine, in healthy infants (PNEU-PED). Vaccine 2023 Jan 6:S0264-410X(22)01575-4. doi: 10.1016/j.vaccine.2022.
PMID: 36621410